Intellectual Property

Recce Pharmaceuticals currently has four wholly owned patent families, which include over 30 patents or patent applications and are constantly expanding, broadening, and developing the intellectual property portfolio.

Recce is committed to protecting its intellectual property estate of patent rights and trade secrets as well as the potential commercial and/or clinical advantages this protection provides for its proprietary technology.

Recce’s patent portfolio includes issued patents and patent applications in the world’s major markets, including the United States, Europe, Japan, China and Australia.